Korean J Fam Med Search

CLOSE


Korean J Fam Med > Volume 45(6); 2024 > Article
Cho, Park, Kim, Choi, Park, Kim, Lee, Shin, and Ha: Association between Combustible Cigarettes and Noncombustible Nicotine or Tobacco Products and Generalized Anxiety Disorder Based on Data from the 8th Korea National Health and Nutrition Examination Survey 2021

Abstract

Background

Despite the increasing prevalence of anxiety disorders in Korea, there have been no nationwide studies on the association between tobacco status and generalized anxiety disorder (GAD). Furthermore, despite the increasing number of people using noncombustible nicotine or tobacco products (NNTPs), the association between NNTP use and GAD remains unclear. Therefore, this study investigated the association between tobacco use and GAD.

Methods

This nationwide study used data from the 8th Korea National Health and Nutrition Examination Survey (2021) and included 5,454 adults aged ≥19 years who self-reported on the tobacco use and mental health sections. Multivariable logistic regression analysis was performed to investigate the odds ratios (ORs) of GAD (Generalized Anxiety Disorder-7 score ≥10) according to tobacco status among Korean adults. The severity of anxiety was assessed using the Generalized Anxiety Disorder-7 scale.

Results

Compared to never tobacco users, the ORs of GAD for combustible cigarette smokers and NNTP users were 2.74 (95% confidence interval [CI], 1.66–4.50) and 2.11 (95% CI, 1.16–3.83), respectively. The OR of GAD for former tobacco users was 1.63 (95% CI, 0.98–2.72).

Conclusion

Tobacco use (combustible cigarettes and NNTP) was positively associated with GAD. However, in former tobacco users, there was no significant association with GAD when compared with never tobacco users. Given the OR of GAD among tobacco users, it is crucial to pay attention to screening for GAD and implement appropriate early interventions.

INTRODUCTION

Generalized anxiety disorder (GAD) is characterized by chronic anxiety and excessive worry in a variety of situations. According to the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition, GAD involves excessive concerns about everyday situations, heightened tension, and physical symptoms. These symptoms can diminish the quality of life and must persist for at least 6 months before diagnosis [1].
Individually, GAD can reduce a person’s quality of life and affect their physical health and relationships [2]. Socially, it can reduce job performance and social participation, and nationally, it can have effects such as increased healthcare costs and decreased productivity [3]. According to a recent report from the Korean Ministry of Health and Welfare, the lifetime prevalence of GAD in Korea was 1.7%, with a 1-year prevalence of 0.4% [4].
Recent data released by the Korea Health Insurance Review and Assessment Service indicate a notable increase in the number of patients with anxiety. Between 2017 and 2021, there was a 32% increase in anxiety cases, totaling 875,108 individuals. Studies have investigated the association between tobacco use and GAD. However, in Korea, only a few studies with small numbers of participants have reported an association between tobacco use and the severity of anxiety symptoms [5].
Recently, the global use of noncombustible nicotine or tobacco products (NNTPs) has increased. According to Organization for Economic Cooperation and Development health data from 2021, Korea’s NNTP usage rate is 5.9%, ranking it as the third-highest country in the world [6]. Nevertheless, no studies have been conducted on the association between NNTP use and GAD in Korean adults. Therefore, we investigated the association between tobacco status and GAD using extensive population data from the Korea National Health and Nutrition Examination Survey (KNHANES).

METHODS

1. Data Source

This study was based on data from the KNHANES VIII (2021). The KNHANES has been conducted in South Korea since 1998 by the Division of Chronic Disease Surveillance of the Korea Disease Control and Prevention Agency (formerly, Korea Centers for Disease Control and Prevention) and the Korean Ministry of Health and Welfare. This population-based cross-sectional survey employs stratified multistage probability sampling units based on geographical area, sex, and age, which are determined from the household registries of the National Census Registry, and assesses the health and nutritional status of the nationwide Korean population. The survey consists of questionnaires regarding the participants’ health interviews, health examinations, and nutrition. The Institutional Review Board Committee of Korea University Hospital exempted this study from informed consent because it utilized publicly available data provided by KNHANES 2021. As this study employed a retrospective design using publicly accessible data, the requirement for informed consent from individual patients was omitted.

2. Study Population

This study examined data obtained from a representative sample from the KNHANES VIII (2021). The data were limited to 2021, because the Generalized Anxiety Disorder-7 (GAD-7) surveys were conducted only during that year. As shown in Figure 1, the study population included Koreans (n=7,090) who completed a health checkup survey. Individuals under 19 years of age (n=1,138), for whom tobacco use is legally prohibited, were excluded. Among the participants aged 19 years and older (n=5,952), those who reported being never tobacco users (n=3,329) but had a urine cotinine level of 100 ng/mL were excluded (n=176). In addition, participants with missing GAD-7 (n=322) or tobacco status data were excluded. Finally, 5,454 adults were included in the analysis.

3. Definitions of Tobacco Status

The “combustible cigarette smoker” was defined as an individual who has smoked more than 100 combustible cigarettes in their lifetime, currently smoke combustible cigarettes, and do not currently use NNTPs, including heated tobacco products or electronic (e)-cigarettes [7]. The “NNTP only users” was defined as an individual who currently uses only NNTPs, including heated tobacco products or e-cigarettes, and do not currently use combustible cigarettes. The “combustible cigarette and NNTP user” was defined as an individual who has smoked more than 100 combustible cigarettes in their lifetime, currently smokes combustible cigarettes, and currently uses NNTPs. The “NNTP user” includes both NNTP only users and combustible cigarette and NNTP users. The “former tobacco user” was defined as an individual who has smoked more than 100 combustible cigarettes in their lifetime and has used NNTPs, including heated tobacco products or e-cigarettes, but does not currently use either. The “never tobacco user” was defined as an individual who has smoked fewer than 100 combustible cigarettes in their lifetime or has never smoked at all and has never used NNTPs, including heated tobacco products or e-cigarettes.

4. Definition of Generalized Anxiety Disorder

The GAD-7 questionnaire, which consists of seven questions, is a widely used screening tool for GAD [8,9]. Participants subjectively evaluate anxiety-related symptoms for each question and are assigned scores ranging from 0 to 3 based on personal experiences. GAD-7 total scores are categorized as follows: 0–4 points indicate minimal anxiety, 5–9 points suggest mild anxiety, 10–14 points imply moderate anxiety, and 15 or higher points signify severe anxiety. A score of 10 or higher indicates a high risk of GAD, with a reported sensitivity of 89% and specificity of 82% for diagnosing GAD. We used a cutoff value of 10 to determine the prevalence of GAD within our sample [10-12].

5. Covariates

Participants in the KNHANES were asked about their demographic and social lifestyle factors and medical conditions. These factors included sex, age, education, household income, urban residence, marital status, occupation, alcohol or cigarette use, and a confirmed diagnosis of any comorbidities. Participants were asked about their highest level of educational attainment. Those with a high school diploma or higher were identified as the highly educated group. Monthly household income was divided into quartiles, and those in the lowest quartile were identified as the lower-income group. Additionally, the participants were categorized into two groups based on their residential location, marital status, and occupational status at the time of the survey. Body mass index was determined by dividing weight (kg) by the square of height (m) and classified according to Asian standards into different categories: normal (18.5–22.9 kg/m2), pre-obese (23–24.9 kg/m2), and obese class I–III (≥25 kg/m2). The history of certain comorbidities was determined by answering “yes” to questions regarding the diagnosis of specific diseases. These diseases include hypertension, type 2 diabetes, dyslipidemia, cardiovascular diseases, stroke, and rheumatism. Psychosocial factors were analyzed, including variables such as perceived high stress, depressive mood lasting for more than 2 weeks, and experiencing suicidal thoughts within the past year. Urine cotinine levels were measured using gas chromatography-mass spectrometry with a Perkin Elmer Clarus 600 T detector (Perkin Elmer, Turku, Finland).

6. Statistical Analysis

Data from the KNHANES were extracted using a complex sampling design, specifically, a two-stage stratified probability sampling method. This design incorporates elements such as strata, clusters, and weights. To ensure the representativeness of the sample and accurate variance estimation, the analysis considered missing data and the incorporation of weights, strata, and cluster elements. For statistical analysis, the Rao-Scott chi-square test was used for categorical data, whereas t-tests were used for continuous data. When the outcome variable was nominal, a generalized logistic model, specifically the generalized logit model, was used for the analysis. Multivariate-adjusted odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multiple logistic regression to evaluate the association between tobacco use and GAD. Model 1 was analyzed after adjusting for sex and age. Model 2 was analyzed after adjusting for general characteristics, including educational level, household income, residential location, marital status, and occupational status. KNHANES data were analyzed using the SAS ver. 9.3 (SAS Institute Inc., Cary, NC, USA) to reflect the complex sampling design and sampling weights of the KNHANES and represent Korean population estimates. Two-tailed P-values of <0.05 were considered statistically significant.

RESULTS

1. Baseline Characteristics Based on Tobacco Status

Table 1 presents an overview of the characteristics based on tobacco status: combustible cigarette smokers (n=763, 14.0%), NNTP users (n=239, 4.4%), former tobacco users (n=1,123, 20.6%), and never tobacco users (n=3,329, 61.0%). The mean age was 46.6 years for combustible cigarette smokers, which was higher than the mean age (37.1 years) of NNTP users (P<0.0001). The group aged 50 years or older had the highest proportions of NNTP users and never tobacco users (P<0.0001). The highest proportion of NNTP users was found among those aged 19–29 years (P<0.0001). Higher proportions of individuals with a high education level, high household income, urban residency, and employment were found among NNTP users than among combustible cigarette smokers and never tobacco users (all P<0.001). Former tobacco users comprised the highest proportion of married individuals (P<0.001). Both combustible cigarette smokers and NNTP users exhibited significantly higher rates of experiencing high stress and depressive mood for over 2 weeks than never tobacco users (P<0.0001). Never tobacco users exhibited a lower prevalence of obesity and a smaller proportion of heavy drinkers than combustible cigarette smokers and NNTP users (P<0.0001).

2. Prevalence of Generalized Anxiety Disorder according to Tobacco Status

As shown in Table 2, the prevalence of GAD was 5.8% among combustible cigarette smokers and 4.8% among NNTP users. The prevalence of GAD was 3.1% in former tobacco users and 4.1% in never tobacco users. However, there was no statistically significant difference in GAD prevalence among the four groups (P=0.0521).

3. Association between Tobacco Status and Generalized Anxiety Disorder

Table 3 shows the results of the multivariable logistic regression analyses performed to examine the relationship between tobacco status and GAD. In model 1, the adjusted OR for GAD in the combustible cigarette smokers, compared to the never tobacco users, was 2.79 (95% CI, 1.72–4.55), and the adjusted OR for GAD in the NNTP users was 2.09 (95% CI, 1.16–3.75). However, there was no significant association with GAD in former tobacco users (OR, 1.63; 95% CI, 0.98–2.72). In model 2, the adjusted OR for GAD in combustible cigarette smokers compared to never tobacco users was 2.74 (95% CI, 1.66–4.50) and the adjusted OR for GAD in NNTP users was 2.11 (95% CI, 1.16–3.83). However, in the former tobacco users, there was no significant association in OR for GAD when compared to never tobacco users (OR, 1.63; 95% CI, 0.98–2.72). In addition, we examined the association between combustible cigarettes and NNTP, NNTP only, and GAD (Supplement 1). The use of NNTP only was associated with an increased risk of GAD (OR, 2.67; 95% CI, 1.39–5.12). Supplement 2 shows the association between tobacco use and GAD according to sex. Women who smoked combustible cigarettes had a significantly higher risk of developing GAD (P<0.05).

4. Subgroup Analysis

We performed stratified analyses according to sex, age, education level, household income, residential location, marital status, occupational status, obesity, alcohol consumption, mental health (perceived stress, depressive mood, and suicidal thoughts), comorbidities, hypertension, diabetes mellitus, dyslipidemia, cardiovascular disease, stroke, and rheumatism) (Table 4). The association between combustible cigarette smokers and GAD did not differ across most subgroups, including sex, age, education level, household income, residential location, marital status, obesity, alcohol consumption, depressive mood, suicidal thoughts, hypertension, diabetes mellitus, and dyslipidemia (P for interaction=0.240, 0.809, 0.681, 0.261, 0.283, 0.793, 0.315, 0.599, 0.325, 0.374, 0.236, and 0.978, respectively) but did differ for some subgroups including occupational status, perceived stress, cardiovascular disease, stroke, rheumatism (P for interaction=0.018, <0.001, <0.001, <0.001, and <0.001, respectively).

DISCUSSION

Our results revealed that within the adult population in South Korea, in both combustible cigarette smokers and NNTP users, tobacco use was significantly associated with GAD compared to never tobacco users. However, among former tobacco users, there was no significant association with GAD when compared to never tobacco users.
Reviewing previous studies on the correlation between tobacco use and anxiety, Morissette et al. [13] indicated that combustible cigarette smoking increases the risk of developing anxiety disorders later, whereas Taylor et al. [14] reported that quitting smoking is associated with a reduction in anxiety compared with continuing to smoke. Zvolensky et al. [15] provided evidence of a positive association between anxiety and e-cigarette use.
A review article by Moylan et al. [16] mentioned that the association between tobacco use and anxiety may be linked to various pathways, including neurotransmitters, neurobiology, respiratory health, and autonomic regulation. However, research on the association between combustible cigarette smoking and GAD has been conducted only in specific generations or with small populations within Korea [17-19]. However, our study is the first nationwide investigation to explore the association between tobacco use and GAD among Korean adults, rather than specific generations.
Recently, Kim et al. [20] examined the motives for e-cigarette use using data from the 6th KNHANES. According to their findings, 41.5% of participants believed that e-cigarette use could assist in quitting smoking, and 18.5% perceived e-cigarettes as less harmful than combustible cigarettes [20].
According to research conducted in the United States, e-cigarette users were found to have a 39% higher risk of developing chronic respiratory conditions (such as chronic bronchitis, chronic obstructive pulmonary disease, pulmonary fibrosis, and asthma) than never tobacco users [21]. In another study, e-cigarette users were found to have a 1.8 times higher risk of myocardial infarction than never tobacco users, which was slightly lower than the 2.7 times higher risk observed in daily combustible cigarette smokers [22,23]. Despite various research findings indicating the health risks of e-cigarettes, there is a tendency for people to overlook such hazards. Our results indicate that both NNTP users and combustible cigarette smokers have significantly higher odds of developing GAD than never tobacco users, although no significant association was observed between former tobacco use and GAD. Therefore, quitting not only combustible cigarette smoking but also NNTP use is important.
Our study has some limitations. First, the data were limited to 2021 because the GAD-7 surveys were conducted in 2021. Second, the GAD-7 questionnaire was used to assess GAD instead of a structured psychiatric interview, potentially leading to an underestimation of GAD prevalence owing to its self-reporting nature. Third, this study used a cross-sectional design to analyze a sample of the general population. Therefore, causal relationships could not be explored. Nonetheless, a strength of this study is the analysis of data from a large-scale national survey, the KNHANES, which are representative of the Korean population.
In conclusion, regardless of the type of tobacco (NNTPs or combustible cigarettes), tobacco use was positively associated with GAD. However, there was no significant association between the former use of tobacco and GAD. Based on these findings, tobacco use can serve as a triggering or exacerbating factor for individuals who frequently experience anxiety and could effectively motivate them to contemplate quitting not only combustible cigarette smoking but also NNTP use. Additionally, it is crucial to pay attention to screening for GAD and implement appropriate early interventions.

Notes

CONFLICT OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING

This research was supported by the Korea Medical Institute Research Fund (Q2126041) and the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Republic of Korea (2022R1I1A1A01054327).

SUPPLEMENTARY MATERIALS

Supplementary materials can be found via https://doi.org/10.4082/kjfm.23.0172.
Supplement 1.
Prevalence and adjusted odds ratio of GAD according to tobacco status (combustible cigarette and NNTP users and NNTP-only users)
kjfm-23-0172-Supplementary-1.pdf
Supplement 2.
Prevalence and adjusted odds ratios of GAD according to tobacco status (combustible cigarette smokers and NNTP users)
kjfm-23-0172-Supplementary-2.pdf

Figure. 1.
Inclusion and exclusion flow chart. KNHANES, Korea National Health and Nutrition Examination Survey; NNTP, noncombustible nicotine or tobacco product.
kjfm-23-0172f1.jpg
Table 1.
Baseline characteristics of the study population
Characteristic Combustible cigarette smokers NNTP users Former tobacco users Never tobacco users P-value
No. of participants 763 239 1,123 3,329
Sex <0.001
 Men 631 (84.2) 190 (82.3) 965 (87.0) 669 (25.7)
 Women 132 (15.8) 49 (17.7) 158 (13.0) 2,660 (74.3)
Age (y) 46.6±0.7 37.1±0.8 53.9±0.7 48.6±0.5 <0.001
 19–29 95 (17.8) 68 (31.4) 57 (7.1) 420 (18.4)
 30–39 87 (15.2) 57 (27.5) 95 (13.7) 383 (16.2)
 40–49 168 (22.9) 70 (24.8) 154 (16.2) 518 (17.4)
 ≥50 413 (44.1) 44 (16.2) 817 (63.0) 2,008 (48.0)
Educational level <0.001
 <High school 193 (18.5) 11 (3.8) 289 (20.0) 1,031 (22.5)
 ≥High school 524 (81.5) 221 (96.2) 758 (80.0) 2,129 (77.5)
Household income 0.002
 1st–2nd quartile (low) 351 (39.1) 64 (24.7) 499 (36.6) 1,457 (36.9)
 3rd–4ht quartile (high) 410 (61.0) 174 (75.3) 621 (63.4) 1,854 (63.1)
Residence location 0.001
 Urban 590 (84.2) 213 (91.6) 865 (81.9) 2,559 (83.6)
 Rural 173 (15.8) 26 (8.4) 258 (18.1) 770 (16.4)
Marital status <0.001
 Single 181 (29.7) 101 (45.2) 124 (14.8) 615 (26.1)
 Married 582 (70.3) 138 (54.8) 999 (85.2) 2,714 (73.9)
Occupational status <0.001
 Employed 495 (69.0) 182 (78.4) 675 (64.5) 1,749 (55.3)
 Unemployed 222 (31.0) 50 (21.6) 372 (35.5) 1,415 (44.7)
Mental illness
 Perceived high stress 660 (87.6) 219 (90.0) 890 (81.9) 2,707 (83.4) 0.001
 Depressive mood 120 (14.4) 21 (7.6) 97 (8.8) 407 (11.5) 0.003
 Suicidal though 65 (8.2) 13 (4.7) 44 (3.5) 116 (3.2) <0.001
Body mass index (kg/m2) <0.001
 Underweight (<18.5) 31 (3.7) 12 (4.2) 31 (2.4) 160 (5.3)
 Normal (18.5–22.9) 239 (31.4) 67 (30.0) 304 (26.5) 1,307 (42.0)
 Pre-obese (23–24.9) 189 (24.7) 49 (19.9) 291 (24.8) 715 (20.4)
 Obese I–III (≥25) 298 (40.1) 109 (46.0) 475 (46.2) 1,077 (32.3)
Alcohol drinking <0.001
 ≤1 time/mo 252 (32.5) 84 (36.3) 501 (43.5) 1,818 (64.8)
 2–4 times/mo 196 (27.1) 69 (31.1) 242 (23.7) 605 (24.6)
 2–3 times/wk 173 (25.7) 63 (24.2) 226 (22.2) 220 (8.4)
 ≥4 times/wk 119 (14.7) 21 (8.5) 121 (10.7) 67 (2.3)
Comorbidity
 Hypertension 197 (20.6) 31 (11.4) 404 (29.7) 913 (20.6) <0.001
 Diabetes 110 (12.5) 10 (3.3) 191 (14.5) 346 (7.7) <0.001
 Hyperlipidemia 146 (16.2) 24 (8.9) 305 (25.7) 834 (19.3) <0.001
 Cardiovascular disease 29 (2.5) 4 (1.1) 59 (3.7) 86 (1.9) <0.001
 Stroke 12 (1.0) 1 (0.5) 47 (3.1) 63 (1.5) <0.001
 Rheumatism 8 (0.8) 1 (0.2) 21 (1.4) 72 (1.6) <0.001

Values are presented as number, number (%), or mean±standard deviation.

NNTP, noncombustible nicotine or tobacco product.

Table 2.
Prevalence of GAD according to tobacco status
Variable Combustible cigarette smokers NNTP users Former tobacco users Never tobacco users P-value
No. of participants 763 239 1,123 3,329
Level of anxiety severity* 0.0521
 Minimal anxiety 632 (83.8) 191 (81.8) 988 (88.0) 2,798 (83.4)
 Mild anxiety 80 (10.5) 33 (13.4) 98 (9.0) 374 (12.5)
 Moderate anxiety 32 (4.3) 9 (3.3) 19 (2.0) 90 (2.7)
 Severe anxiety 18 (1.5) 6 (1.5) 16 (1.1) 55 (1.3)
Prevalence of GAD 40 (5.8) 15 (4.8) 35 (3.1) 55 (4.0)

Values are presented as number or number (%).

GAD, generalized anxiety disorder; NNTP, noncombustible nicotine or tobacco product.

* Generalized Anxiety Disorder-7 score defined as minimal anxiety (score 0–4), mild anxiety (score 5–9), moderate anxiety (score 10–14), and severe anxiety (score 15–21).

Prevalence of GAD (%)=(numbers of individuals with the moderate, severe anxiety/total population)×100.

Table 3.
Adjusted odds ratios and 95% confidence intervals of prevalence of generalized anxiety disorder according to tobacco status
Variable Model 1 Model 2
Combustible cigarette smokers 2.79 (1.72–4.55) 2.74 (1.66–4.50)
NNTP users 2.09 (1.16–3.75) 2.11 (1.16–3.83)
Former tobacco users 1.56 (0.95–2.56) 1.63 (0.98–2.72)
Never tobacco users 1 (Reference) 1 (Reference)

Values are presented as odds ratio (95% confidence interval).

Model 1: adjusted for age, and sex. Model 2: additionally adjusted for educational level, household income, residence location, marital status, and occupational status.

NNTP, noncombustible nicotine or tobacco product.

Table 4.
Subgroup analysis of the association between combustible cigarette smoking and generalized anxiety disorder
Subgroup Adjusted OR* (95% CI) P for interaction
Sex
 Men 1.75 (0.84–3.37) 0.240
 Women 3.42 (0.96–12.17)
Age (y)
 <50 2.79 (1.48–5.25) 0.809
 ≥50 1.87 (0.65–5.36)
Educational level
 <High school 2.69 (1.09–6.66) 0.681
 ≥High school 2.42 (0.67–8.75)
Household income
 1st–2nd quartile (low) 4.11 (2.09–8.11) 0.261
 3rd–4th quartile (high) 4.33 (1.53–12.27)
Residence location
 Urban 18.79 (4.79–73.70) 0.283
 Rural 6.52 (2.64–16.12)
Marital status
 Single 2.92 (1.40–6.07) 0.793
 Married 2.26 (0.84–6.11)
Occupational status
 Employed 1.57 (0.78–3.14) 0.018
 Unemployed 1.24 (0.46–3.34)
Obesity
 Obese 3.13 (1.31–7.48) 0.315
 Non-obese 2.67 (1.47–4.85)
Alcohol drinking
 Light drinker 2.85 (1.60–5.09) 0.599
 Heavy drinker 6.17 (2.49–15.26)
Perceived high stress
 Yes 84.27 (1.04–6822.3) <0.001
 No 3.2 (0.19–52.00)
Depressive mood
 Yes 12.76 (3.89–41.90) 0.325
 No 1.09 (0.45–2.63)
Suicidal though
 Yes 11.69 (4.61–29.65) 0.374
 No 1.41 (0.76–2.65)
Hypertension
 Yes 3.54 (1.45–8.60) 0.236
 No 2.67 (1.52–4.70)
Diabetes mellitus
 Yes 4.76 (1.86–12.15) 0.978
 No 2.7 (1.59–4.53)
Dyslipidemia
 Yes 4.32 (1.66–11.23) 0.869
 No 2.5 (1.40–4.46)
Cardiovascular disease
 Yes 5.72 (1.63–20.01) <0.001
 No 2.8 (1.67–4.68)
Stroke
 Yes 2.62 (1.62–14.79) <0.001
 No 2.71 (0.46–14.79)
Rheumatism
 Yes 4.72 (0.89–25.22) <0.001
 No 2.64 (1.56–4.45)

OR, odds ratio; CI, confidence interval

* Adjusted for age, sex, educational level, household income, residence location, marital status, and occupational status.

REFERENCES

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington (VA): American Psychiatric Publishing Inc; 2013.

2. Barrera TL, Norton PJ. Quality of life impairment in generalized anxiety disorder, social phobia, and panic disorder. J Anxiety Disord 2009;23:1086-90.
crossref pmid pmc
3. Wittchen HU. Generalized anxiety disorder: prevalence, burden, and cost to society. Depress Anxiety 2002;16:162-71.
crossref pmid
4. Rim SJ, Hahm BJ, Seong SJ, Park JE, Chang SM, Kim BS, et al. Prevalence of mental disorders and associated factors in Korean adults: National Mental Health Survey of Korea 2021. Psychiatry Investig 2023;20:262-72.
crossref pmid pmc pdf
5. Shin HM, Lee SJ, Ko WR, Jeong JY, Koh SB, Do KY. Association between second-hand smoke and generalized anxiety disorder in Korean adolescents: based on the 17th Korea Youth Risk Behavior Survey. J Health Inf Stat 2022;47:222-31.
crossref pdf
6. Organization for Economic Cooperation and Development. OECD health statistics: health status (edition 2022). Paris: OECD Publishing; 2023.

7. Choi S, Lee K, Park SM. Combined associations of changes in noncombustible nicotine or tobacco product and combustible cigarette use habits with subsequent short-term cardiovascular disease risk among South Korean men: a nationwide cohort study. Circulation 2021;144:1528-38.
crossref pmid
8. Spitzer RL, Kroenke K, Williams JB, Lowe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092-7.
crossref pmid
9. Seo JG, Park SP. Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015;16:97.
crossref pmid pmc pdf
10. Kim SJ, Lamichhane DK, Park SG, Lee BJ, Moon SH, Park SM, et al. Association between second-hand smoke and psychological well-being amongst non-smoking wageworkers in Republic of Korea. Ann Occup Environ Med 2016;28:49.
crossref pmid pmc pdf
11. Do EY, Hong YR. Factors influencing life satisfaction of first year university students. J Health Inf Stat 2021;46:442-9.
crossref pdf
12. Omani-Samani R, Ghaheri A, Navid B, Sepidarkish M, Maroufizadeh S. Prevalence of generalized anxiety disorder and its related factors among infertile patients in Iran: a cross-sectional study. Health Qual Life Outcomes 2018;16:129.
crossref pmid pmc pdf
13. Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT. Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships. Psychol Bull 2007;133:245-72.
crossref pmid
14. Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P. Change in mental health after smoking cessation: systematic review and meta-analysis. BMJ 2014;348:g1151.
crossref pmid pmc
15. Zvolensky MJ, Mayorga NA, Garey L. Positive expectancies for e-cigarette use and anxiety sensitivity among adults. Nicotine Tob Res 2019;21:1355-62.
crossref pmid
16. Moylan S, Jacka FN, Pasco JA, Berk M. How cigarette smoking may increase the risk of anxiety symptoms and anxiety disorders: a critical review of biological pathways. Brain Behav 2013;3:302-26.
crossref pmid pmc
17. Kim EM. Factors associated with smoking behaviors according to the types of cigarettes, conventional and electronic, among adolescents. J Korean Soc Sch Health 2022;35:65-74.

18. Byeon H. Association among smoking, depression, and anxiety: findings from a representative sample of Korean adolescents. PeerJ 2015;3:e1288.
crossref pmid pmc pdf
19. Ko KD, Cho YT, Cho SI, Sung JH, Cho BL, Son KY, et al. Association of health risk behaviors with mental health among elderly Koreans. J Korean Geriatr Soc 2012;16:66-73.
crossref
20. Kim YA, Lee J, Kim J, Kim J, Ko YJ, Kim S. The characteristics of electronic cigarette user among Korean smokers: the sixth Korean national health and nutrition examination Survey, 2013-2015. Korean J Fam Pract 2019;9:324-30.
crossref
21. Bhatta DN, Glantz SA. Association of e-cigarette use with respiratory disease among adults: a longitudinal analysis. Am J Prev Med 2020;58:182-90.
crossref pmid pmc
22. Alzahrani T, Pena I, Temesgen N, Glantz SA. Association between electronic cigarette use and myocardial infarction. Am J Prev Med 2018;55:455-61.
crossref pmid pmc
23. Bhatta DN, Glantz SA. Electronic cigarette use and myocardial infarction among adults in the US population assessment of tobacco and health. J Am Heart Assoc 2019;8:e012317.
crossref pmid pmc


ABOUT
ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES
INFORMATION FOR AUTHORS AND REVIEWERS
Editorial Office
Room 2003, Gwanghwamun Officia, 92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
Tel: +82-2-3210-1537    Tax: +82-2-3210-1538    E-mail: kjfm@kafm.or.kr                

Copyright © 2024 by Korean Academy of Family Medicine.

Developed in M2PI

Close layer
prev next